Vaxxinity (VAXX) Stock Chart & Stock Price History → Unlock the Power of Stock Options - Join Our Webinar! (From OIC) (Ad) Free VAXX Stock Alerts $0.08 +0.00 (+2.17%) (As of 10:21 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Vaxxinity Stock Price Performance5 Day Performance-2.44%1 Month Performance-43.30%3 Month Performance-89.91%6 Month Performance-90.81%Year-To-Date Performance-90.59%1 Year Performance-95.96% Receive VAXX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vaxxinity and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. VAXX Stock Chart for Monday, June, 3, 2024 VAXX Chart by TradingView Vaxxinity Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.08$0.08-1.93%$0.09$0.08439,597 shs$10.32 million05/30/2024$0.08$0.08+1.22%$0.09$0.06408,504 shs$10.52 million05/29/2024$0.09$0.08-8.89%$0.09$0.08128,323 shs$10.39 million05/28/2024$0.08$0.09+12.50%$0.09$0.08431,176 shs$11.41 million05/27/2024$0.08$0.08$0.09$0.0759,700 shs$10.14 million05/24/2024$0.07$0.08+9.59%$0.09$0.0759,715 shs$10.14 million Get the Latest News and Ratings for VAXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaxxinity and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.08$0.07-8.75%$0.09$0.07416,735 shs$9.25 million05/22/2024$0.08$0.08-3.85%$0.09$0.08436,462 shs$10.14 million05/21/2024$0.09$0.08-11.49%$0.09$0.08399,617 shs$10.55 million05/20/2024$0.08$0.09+16.05%$0.10$0.06594,123 shs$11.91 million05/17/2024$0.05$0.08+50.00%$0.09$0.061.23 million shs$10.27 million05/16/2024$0.05$0.05$0.07$0.05873,681 shs$6.84 million05/15/2024$0.06$0.05-10.00%$0.07$0.05873,681 shs$6.84 million05/14/2024$0.05$0.06+25.00%$0.07$0.051.45 million shs$7.61 million05/13/2024$0.05$0.05-5.88%$0.06$0.051.16 million shs$6.08 million05/10/2024$0.11$0.05-54.10%$0.11$0.052.86 million shs$6.46 million05/09/2024$0.11$0.11$0.12$0.07349,657 shs$14.08 million05/08/2024$0.13$0.11-15.26%$0.12$0.112.88 million shs$14.08 million05/07/2024$0.13$0.13+0.85%$0.13$0.121.75 million shs$16.62 million05/06/2024$0.14$0.13-7.87%$0.13$0.125.20 million shs$17.88 million05/03/2024$0.10$0.14+35.41%$0.15$0.1256.30 million shs$17.88 million05/02/2024$0.11$0.10-9.08%$0.12$0.1011.27 million shs$13.21 million05/01/2024$0.12$0.11-6.60%$0.13$0.112.38 million shs$14.53 million04/30/2024$0.15$0.12-20.07%$0.16$0.122.19 million shs$15.55 million04/29/2024$0.12$0.15+31.65%$0.18$0.116.21 million shs$19.46 million04/26/2024$0.12$0.12-3.95%$0.13$0.111.97 million shs$14.78 million04/25/2024$0.13$0.12-8.45%$0.14$0.122.93 million shs$15.39 million04/24/2024$0.20$0.13-33.70%$0.20$0.134.89 million shs$16.81 million04/23/2024$0.27$0.20-25.82%$0.25$0.202.08 million shs$25.35 million04/22/2024$0.48$0.27-43.37%$0.29$0.195.85 million shs$34.17 million04/19/2024$0.46$0.48+2.43%$0.48$0.41293,230 shs$60.35 million04/18/2024$0.42$0.46+11.20%$0.48$0.42435,167 shs$58.91 million04/17/2024$0.44$0.42-4.96%$0.46$0.40311,425 shs$52.98 million04/16/2024$0.45$0.44-1.41%$0.50$0.39440,673 shs$55.75 million04/15/2024$0.49$0.45-8.44%$0.54$0.44447,759 shs$56.54 million04/12/2024$0.53$0.49-7.73%$0.55$0.48459,341 shs$61.75 million04/11/2024$0.61$0.53-13.44%$0.64$0.521.26 million shs$66.92 million04/10/2024$0.65$0.61-5.81%$0.66$0.60393,134 shs$77.32 million04/09/2024$0.63$0.65+2.06%$0.67$0.64149,374 shs$82.08 million04/08/2024$0.66$0.63-3.25%$0.69$0.62282,554 shs$80.42 millionThe Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/05/2024$0.66$0.66-1.22%$0.68$0.65137,145 shs$83.12 million04/04/2024$0.68$0.66-2.80%$0.70$0.65125,682 shs$84.15 million04/03/2024$0.69$0.68-1.24%$0.70$0.67141,220 shs$86.57 million04/02/2024$0.71$0.69-2.59%$0.72$0.66176,304 shs$87.66 million04/01/2024$0.72$0.71-1.05%$0.74$0.71150,525 shs$89.99 million03/29/2024$0.72$0.72$0.73$0.67341,754 shs$90.94 million03/28/2024$0.69$0.72+4.14%$0.73$0.67338,465 shs$90.94 million03/27/2024$0.65$0.69+6.00%$0.71$0.67248,850 shs$87.33 million03/26/2024$0.66$0.65-2.09%$0.70$0.62320,657 shs$82.39 million03/25/2024$0.71$0.66-6.41%$0.75$0.66320,095 shs$84.15 million03/22/2024$0.71$0.71-0.03%$0.73$0.70137,945 shs$89.92 million03/21/2024$0.70$0.71+0.91%$0.73$0.69199,038 shs$89.94 million03/20/2024$0.74$0.70-4.33%$0.75$0.69345,944 shs$89.13 million03/19/2024$0.72$0.74+1.72%$0.74$0.7197,923 shs$93.16 million03/18/2024$0.76$0.72-4.48%$0.77$0.71195,541 shs$91.59 million03/15/2024$0.70$0.76+7.76%$0.77$0.70368,617 shs$95.89 million03/14/2024$0.76$0.70-7.63%$0.77$0.68241,373 shs$88.98 million03/13/2024$0.77$0.76-1.71%$0.80$0.73265,024 shs$96.33 million03/12/2024$0.74$0.77+5.00%$0.81$0.70434,586 shs$98.00 million03/11/2024$0.70$0.74+5.87%$0.76$0.68433,463 shs$93.34 million03/08/2024$0.74$0.70-6.18%$0.75$0.68331,173 shs$88.17 million03/07/2024$0.68$0.74+9.58%$0.92$0.573.19 million shs$93.97 million03/06/2024$0.80$0.68-14.89%$0.81$0.66802,917 shs$85.76 million03/05/2024$0.80$0.80-0.61%$0.84$0.78240,385 shs$100.76 million03/04/2024$0.79$0.80+0.92%$0.86$0.78419,661 shs$101.39 million Related Companies: Nabriva Therapeutics Stock Chart Kronos Bio Stock Chart Lexaria Bioscience Stock Chart Clene Stock Chart Gain Therapeutics Stock Chart Ocuphire Pharma Stock Chart Immuneering Stock Chart NextCure Stock Chart HCW Biologics Stock Chart Daré Bioscience Stock Chart Receive VAXX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaxxinity and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VAXX) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersAlert: Your Bank is Dying – Act Now or Lose Everything!Priority GoldDoes this make you sick?Allegiance GoldBill Gates is all about this tiny $2 stockTimothy SykesTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin Pro[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNext President (Not Trump. Not Biden.)The Freeport SocietyHistoric Crash Could Wipe Away Your 401k (Govt Debt Explosion)Birch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxxinity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.